117 related articles for article (PubMed ID: 37341234)
1. Genome sequencing reveals molecular subgroups in oral epithelial dysplasia.
Márquez A; Mujica I; Jordan N; Baez P; Tarquinio S; Nunes J; Adorno D; Martínez B; Morales-Pison S; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e063. PubMed ID: 37341234
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing of oral epithelial dysplasia samples reveals an association with new genes.
Adorno-Farias D; Santos JND; González-Arriagada W; Tarquinio S; Santibáñez Palominos RA; Martín Martín AJ; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e016. PubMed ID: 36790257
[TBL] [Abstract][Full Text] [Related]
3. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.
India Project Team of the International Cancer Genome Consortium
Nat Commun; 2013; 4():2873. PubMed ID: 24292195
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia.
Sawada K; Momose S; Kawano R; Kohda M; Irié T; Mishima K; Kaneko T; Horie N; Okazaki Y; Higashi M; Tamaru JI
Mod Pathol; 2022 Feb; 35(2):177-185. PubMed ID: 34404905
[TBL] [Abstract][Full Text] [Related]
5. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
[TBL] [Abstract][Full Text] [Related]
6. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies.
Abdalla Z; Walsh T; Thakker N; Ward CM
PLoS One; 2017; 12(12):e0187449. PubMed ID: 29216196
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
[TBL] [Abstract][Full Text] [Related]
8. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes.
Xie F; Gleue CA; Deschaine M; Dasari S; Lau JS; Sartori-Valinotti JC; Meves A; Lehman JS
J Oral Pathol Med; 2022 Apr; 51(4):395-404. PubMed ID: 35146808
[TBL] [Abstract][Full Text] [Related]
10. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
12. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
13. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
14. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
17. Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
Sarode GS; Sarode SC; Sengupta N; Sharma NK; Patil S
Oral Oncol; 2021 Jun; 117():105181. PubMed ID: 33500183
[TBL] [Abstract][Full Text] [Related]
18. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).
Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR
Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
